Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with FOLFOX for Unresectable Liver Metastases from Colorectal Cancer
NCT00056030Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2004
- Primary completion
- Oct 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by Cancer and Leukemia Group B. Started Dec 2004; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00056030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056030.